XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.23.3

Earnings Per Share | 9 Months Ended
--- | ---
Sep. 30, 2023
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share Basic earnings per share is calculated using the weighted average number of shares of the Company’s common stock issued and outstanding during a certain period, and is calculated by dividing net income attributable to ApolloMed by the weighted average number of shares of the Company’s common stock issued and outstanding during such period. Diluted earnings per share is calculated using the weighted average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period, using the as-if converted method for secured convertible notes, preferred stock, and the treasury stock method for options and common stock warrants. As of September 30, 2023 and December 31, 2022, APC held 10,299,259 and 10,299,259 shares of ApolloMed’s common stock, respectively, which are treated as treasury shares for accounting purposes and not included in the number of shares of common stock outstanding used to calculate earnings per share. For the three months ended September 30, 2023 and 2022, restricted stock of 243,689 and 192,804, respectively, were excluded from the computation of diluted weighted average common shares outstanding because the assumed proceeds, as calculated under the treasury stock method, resulted in these awards being antidilutive. For the nine months ended September 30, 2023 and 2022, restricted stock of 243,689 and 192,804 were excluded from the computation of diluted weighted average common shares outstanding for being antidilutive. For the three and nine months ended September 30, 2023, 925,558 of contingently issuable shares were excluded from the computation of diluted weighted average common shares outstanding because these conditions were not achieved as of September 30, 2023. For the three and nine months ended September 30, 2022, 290,045 of contingently issuable shares were excluded from the computation of diluted weighted average common shares outstanding because these conditions were not achieved as of September 30, 2022. Below is a summary of the earnings per share computations:
Three Months Ended September 30, |  | 2023 |  | 2022
|  |  |  | (Restated)
Earnings per share – basic |  | $ | 0.47 |  |  | $ | 0.52 |
Earnings per share – diluted |  | $ | 0.47 |  |  | $ | 0.50 |
Weighted average shares of common stock outstanding – basic |  | 46,547,502 |  |  | 44,946,725 |
Weighted average shares of common stock outstanding – diluted |  | 46,920,607 |  |  | 46,152,536 |
Nine Months Ended September 30, |  | 2023 |  | 2022
|  |  |  | (Restated)
Earnings per share – basic |  | $ | 1.04 |  |  | $ | 1.09 |
Earnings per share – diluted |  | $ | 1.03 |  |  | $ | 1.06 |
Weighted average shares of common stock outstanding – basic |  | 46,527,350 |  |  | 44,795,295 |
Weighted average shares of common stock outstanding – diluted |  | 46,881,567 |  |  | 45,993,001 |
Below is a summary of the shares included in the diluted earnings per share computations:
Three Months Ended September 30, |  | 2023 |  | 2022
Weighted average shares of common stock outstanding – basic |  | 46,547,502 |  |  | 44,946,725 |
Stock options |  | 253,767 |  |  | 457,992 |
Warrants |  | — |  |  | 555,065 |
Restricted stock awards |  | 88,450 |  |  | 192,754 |
Contingently issuable shares |  | 30,888 |  |  | — |
Weighted average shares of common stock outstanding – diluted |  | 46,920,607 |  |  | 46,152,536 |
Nine Months Ended September 30, |  | 2023 |  | 2022
Weighted average shares of common stock outstanding – basic |  | 46,527,350 |  |  | 44,795,295 |
Stock options |  | 254,399 |  |  | 455,166 |
Warrants |  | — |  |  | 552,744 |
Restricted stock awards |  | 89,409 |  |  | 189,796 |
Contingently issuable shares |  | 10,409 |  |  | — |
Weighted average shares of common stock outstanding – diluted |  | 46,881,567 |  |  | 45,993,001 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration